Global Pediatric Vaccine Market Technologies, Market share and Industry Forecast to 2024 - ResearchAndMarkets.com

October 8, 2018

DUBLIN--(BUSINESS WIRE)--Oct 8, 2018--The “Global Pediatric Vaccine Market - Technologies, Market share and Industry Forecast to 2024” report has been added to ResearchAndMarkets.com’s offering.

Global pediatric vaccine market is expected to grow with a CAGR of around 12.6% over the forecast period 2017-2024

Key factors contributing the growth of global pediatric vaccine market includes, rise in importance and awareness of immunization across the globe predominance of chronic diseases, technologic advancements and increase in government and non-government funding.

However, cost of immunization and of healthcare infrastructure are some of the growth restricting factors in the market. Whereas, rising concern regarding diseases which are vaccine-preventable across the globe is a key opportunity in the market. Moreover, lack of awareness regarding diseases in the remote areas is expected to deliver challenge towards the market.

Rise in importance and awareness of immunization across the globe over the forecast period is the major factor attributing the growth of the market. Global governments and non-government organizations are focusing efforts regarding vaccine preventable diseases to increase awareness globally.

For instance, programs by World Health Organization, Gavi, Pan America Health Organization, Center for Disease Control and Prevention etc., are providing significant awareness and aids in the immunization field to increase the healthcare in children. As the result of continuous awareness programs and immunization programs across the world, prevalence of polio has decreased in several countries almost by 99% since 1988.

Only 3 countries that are Nigeria, Pakistan and Afghanistan are polio-endemic countries left. In 2016, around 86% of the global children population had received 3 doses of diphtheria-tetanus-pertussis (DTP1) vaccination. Increasing vaccination programs and rising need for preventing fatal disease has significantly increased the adoption of vaccination. However, lack of healthcare infrastructure is a global pediatric vaccine major factor restricting growth of the market.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Global Pediatric Vaccines Market By Type

5. Global Pediatric Vaccines Market By Technology

6. Global Pediatric Vaccines Market By Application

7. Competitive Landscape

8. Geographic Analysis

9. Company Profiles

Astrazeneca. (U.S.) Bio Med Pvt. Ltd. (India) Changchun Changshen Life Sciences Ltd. (China) Glaxosmithkline (U.K.) Indian Immunologicals Limited (India) Intercell AG (Austria) Merck Sharp & Dohme Corp. (U.S.) Mitsubishi Tanabe Pharma Corporation (Japan) Panacea Biotec (India) Pfizer, Inc. (U.S.) Sanofi (France) Serum Institute Of India Pvt. Ltd. (India) Sinovac Biotech Ltd. (China) VFC Corporation (U.S.) Zydus Cadila (India)

For more information about this report visit https://www.researchandmarkets.com/research/smq8g7/global_pediatric?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181008005512/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Vaccines,Pediatrics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/08/2018 10:35 AM/DISC: 10/08/2018 10:35 AM


Update hourly